Glycogen synthase kinase 3β (GSK-3β) catalyses the hyperphosphorylation of tau protein in
the Alzheimer's disease (AD) pathology. A series of novel thieno [3, 2-c] pyrazol-3-amine …

Alzheimer's disease (AD) is a significant 21st-century public health challenge. This article
delves into AD's neurodegenerative complexities, highlighting cognitive decline, memory …

Alzheimer's disease (AD) is a complex neurodegenerative disorder involving cognitive
dysfunction like short-term memory and behavioral changes as the disease progresses due …

Neurodegenerative diseases are challenging to cure. To date, no cure has been found for
Alzheimer's disease or Parkinson's disease, and current treatments are able only to slow the …

Abstract Alzheimer's disease (AD), the most common form of dementia, is characterized by a
progressive decline in cognitive performance and memory formation. The present study was …

COVID-19, which primarily affects the pulmonary system, turned out to be a global
pandemic, whereas the effects on other systems are still unknown. SARS-CoV-2, binds to …

Neurodegenerative diseases (NDs) are characterized by abnormalities within neurons of the
brain or spinal cord that gradually lose function, eventually leading to cell death. Upon …

Amyloid plaques, a major pathological hallmark of Alzheimer's disease (AD), are caused by
an imbalance between the amyloidogenic and non‐amyloidogenic pathways of amyloid …

Alzheimer's disease (AD) is a progressive neurodegenerative disorder, and moderate
exercise holds promise in ameliorating the ongoing neurodegeneration and cognitive …

Alzheimer's disease (AD) is a neurological disorder that affects millions of people worldwide.
There are currently no cures for AD, although various drugs are used to manage the …